Table 3.
Characteristic | Hospitalisation Period 2012–2015 n = 627 |
Hospitalisation Period 2016–2020 n = 1174 |
p Value |
---|---|---|---|
Antimicrobial susceptibility | 364 (58.1%) | 597 (50.9%) | <0.001 |
Antimicrobial resistance other than ESBL, MDR, XDR | 180 (28.7%) | 454 (38.7%) | <0.001 |
ESBL | 26 (4.1%) | 57 (4.9%) | 0.7 |
MDR | 56 (8.9%) | 63 (5.4%) | 0.001 |
XDR | 1 (0.2%) | 3 (0.3%) | >0.9 |
ESBL: extended-spectrum beta-lactamase; MDR: multidrug resistant; XDR: extensively drug resistant.